Phase 1 clinical research results of E7386, Jointly Created by PRISMBioLab and Eisai, Published in ESMO OPEN

Published on: January 22, 2026

PRISM BioLab announces that a paper reporting the results of a domestic Phase I clinical trial on E7386, jointly created with Eisai Co., Ltd. has been published in the ESMO OPEN, the open access medical journal issued by the European Society for Medical Oncology (ESMO).

For more details, please click here.